Featured Research

from universities, journals, and other organizations

'Smart' Nanoprobes Light Up Disease: Quantum Dots Programmed To Glow In Presence Of Enzyme Activity

Date:
August 16, 2005
Source:
Rice University
Summary:
Researchers from Rice University's Center for Biological and Environmental Nanotechnology (CBEN) have developed a "smart" beacon hundreds of times smaller than a human cell that is programmed to light up only when activated by specific diseases. Altered expression of particular proteases is a common hallmark of cancer, atherosclerosis and other diseases. The research appears in the September issue of the journal Biochemical and Biophysical Research Communications.

Quantum dots (red color in image above) glowing after targeting to cancer cells.
Credit: Image courtesy of Rice University

HOUSTON, Aug. 1, 2005 -- Researchers from Rice University's Center forBiological and Environmental Nanotechnology (CBEN) have developed a"smart" beacon hundreds of times smaller than a human cell that isprogrammed to light up only when activated by specific proteases.Altered expression of particular proteases is a common hallmark ofcancer, atherosclerosis, and many other diseases.

Related Articles


In the September issue of the journal Biochemical and Biophysical Research Communications,lead authors Jennifer West, the Isabel C. Cameron Professor ofBioengineering and director of CBEN's biological research program, andRebekah Drezek, the Stanley C. Moore Assistant Professor ofBioengineering and assistant professor of electrical and computerengineering, describe development of a new nanoprobe for visualizationof proteolytic activity in vivo.

"The idea is to develop a 'smart' nanostructure that is dark inits original state but lights up very brightly in the presence ofenzymatic activity associated with a particular disease process," saidWest. "Other groups have used targeted nanostructures including quantumdots for molecular imaging, but they have never been able to adequatelysolve the problem of clearly distinguishing between the 'cancer ishere' signal and the background light which arises from nanostructuresnot specifically bound to their molecular targets."

Rice's technology solves this longstanding problem by usingemissive nanoparticles called quantum dots that give off light in thenear-infrared (NIR), a rare portion of the spectrum that has nobackground component in biomedical imaging. Near-infrared light alsopasses harmlessly through skin, muscle and cartilage, so the new probescould alert doctors to tumors and other diseases sites deep in the bodywithout the need for a biopsy or invasive surgery.

The probe's design makes use of a technique called "quenching"that involves tethering a gold nanoparticle to the quantum dot toinhibit luminescence. The tether, a peptide sequence measuring only afew nanometers, or billionths of a meter, holds the gold close enoughto prevent the quantum dot from giving off its light.

In their test system, the Rice team used a peptide tether thatis cleaved by the enzyme collagenase. The researchers first showed thatluminescence of the quantum dots was cut by more than 70 percent whenthey were attached to the gold particles. They remained dark until thenanostructures were exposed to collagenase after which the luminescencesteadily returned.

Ultimately, the researchers hope to pair a series of quantumdots, each with a unique NIR optical signature, to an index of linkerproteases.

"There is currently a critical need for methods tosimultaneously image the activity of multiple proteases in vivo," saidDrezek. "This is important not only for early detection of severaldiseases, but perhaps more significantly, in understanding andmonitoring the efficacy of therapeutic interventions, including thegrowing class of drugs that act as protease inhibitors. What isparticularly powerful about the protease imaging probes described inthis study is the combination of the contrast enhancement achievablethrough an activateable probe with the imaging advantages provided bythe brightness, photostability, and tunability of quantum dots."

###

CBEN research is funded by the National Science Foundation.


Story Source:

The above story is based on materials provided by Rice University. Note: Materials may be edited for content and length.


Cite This Page:

Rice University. "'Smart' Nanoprobes Light Up Disease: Quantum Dots Programmed To Glow In Presence Of Enzyme Activity." ScienceDaily. ScienceDaily, 16 August 2005. <www.sciencedaily.com/releases/2005/08/050814171326.htm>.
Rice University. (2005, August 16). 'Smart' Nanoprobes Light Up Disease: Quantum Dots Programmed To Glow In Presence Of Enzyme Activity. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2005/08/050814171326.htm
Rice University. "'Smart' Nanoprobes Light Up Disease: Quantum Dots Programmed To Glow In Presence Of Enzyme Activity." ScienceDaily. www.sciencedaily.com/releases/2005/08/050814171326.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins